Tirzepatide, a dual GIP/GLP-1 receptor agonist, represents the newest class of weight loss medications with remarkable clinical trial results from the SURMOUNT studies (Jastreboff et al., NEJM, 2022)
Continuous positive airway pressure with or without liraglutide in obstructive sleep apnoea and type 2 diabetes (ROMANCE)
For this, we suggest enhancing your Metformin remedy with vitamin B12 supplementation
Injection Technique General subcutaneous guidance from clinical best-practice resources [8] [10] [11]
Most clinics follow a standardized titration schedule that increases the dose every four weeks
11,107 After both forms of GLP-1 have been exposed to DPP-IV, they are either rendered inactive or become an antagonist for the GLP-1R